메뉴 건너뛰기




Volumn 45, Issue 10, 2014, Pages 2983-2988

Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: Comparison between patients with versus without stroke

Author keywords

atrial fibrillation; randomized trial; stroke; warfarin

Indexed keywords

CREATININE; WARFARIN; ANTICOAGULANT AGENT; APIXABAN; BENZIMIDAZOLE DERIVATIVE; BETA ALANINE; DABIGATRAN; EDOXABAN; MORPHOLINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIDONE DERIVATIVE; RIVAROXABAN; THIAZOLE DERIVATIVE; THIOPHENE DERIVATIVE;

EID: 84922480892     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005599     Document Type: Article
Times cited : (22)

References (18)
  • 1
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • RE-LY Steering Committee and Investigators
    • Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151.
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3    Eikelboom, J.4    Oldgren, J.5    Parekh, A.6
  • 2
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • ROCKET AF Investigators
    • Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891.
    • (2011) N Engl J Med , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3    Pan, G.4    Singer, D.E.5    Hacke, W.6
  • 3
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • ARISTOTLE Committees and Investigators
    • Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-992.
    • (2011) N Engl J Med , vol.365 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    McMurray, J.J.3    Lopes, R.D.4    Hylek, E.M.5    Hanna, M.6
  • 5
    • 68749089916 scopus 로고    scopus 로고
    • Patients enrolled in large randomized clinical trials of antiplatelet treatment for prevention after transient ischemic attack or ischemic stroke are not representative of patients in clinical practice: The Netherlands Stroke Survey
    • Netherlands Stroke Survey Investigators
    • Maasland L, van Oostenbrugge RJ, Franke CF, Scholte Op Reimer WJ, Koudstaal PJ, Dippel DW; Netherlands Stroke Survey Investigators. Patients enrolled in large randomized clinical trials of antiplatelet treatment for prevention after transient ischemic attack or ischemic stroke are not representative of patients in clinical practice: The Netherlands Stroke Survey. Stroke. 2009;40:2662-2668.
    • (2009) Stroke , vol.40 , pp. 2662-2668
    • Maasland, L.1    Van Oostenbrugge, R.J.2    Franke, C.F.3    Scholte Op Reimer, W.J.4    Koudstaal, P.J.5    Dippel, D.W.6
  • 6
    • 84888349241 scopus 로고    scopus 로고
    • Eligibility for randomized trials of treatments specifically for intracerebral hemorrhage: Community-based study
    • Fonville AF, Samarasekera N, Hutchison A, Perry D, Roos YB, Al-Shahi Salman R. Eligibility for randomized trials of treatments specifically for intracerebral hemorrhage: community-based study. Stroke. 2013;44:2729-2734.
    • (2013) Stroke , vol.44 , pp. 2729-2734
    • Fonville, A.F.1    Samarasekera, N.2    Hutchison, A.3    Perry, D.4    Roos, Y.B.5    Al-Shahi Salman, R.6
  • 7
    • 84878317563 scopus 로고    scopus 로고
    • Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: A population-based study
    • Italian Horizon Scanning Project
    • Joppi R, Cinconze E, Mezzalira L, Pase D, Poggiani C, Rossi E, et al; Italian Horizon Scanning Project. Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: A population-based study. Eur J Intern Med. 2013;24:318-323.
    • (2013) Eur J Intern Med , vol.24 , pp. 318-323
    • Joppi, R.1    Cinconze, E.2    Mezzalira, L.3    Pase, D.4    Poggiani, C.5    Rossi, E.6
  • 9
    • 80052094564 scopus 로고    scopus 로고
    • A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
    • Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011;58:395-401.
    • (2011) J Am Coll Cardiol , vol.58 , pp. 395-401
    • Fang, M.C.1    Go, A.S.2    Chang, Y.3    Borowsky, L.H.4    Pomernacki, N.K.5    Udaltsova, N.6
  • 10
    • 77955872745 scopus 로고    scopus 로고
    • A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey
    • Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest. 2010;138:1093-1100.
    • (2010) Chest , vol.138 , pp. 1093-1100
    • Pisters, R.1    Lane, D.A.2    Nieuwlaat, R.3    De Vos, C.B.4    Crijns, H.J.5    Lip, G.Y.6
  • 11
    • 84896117299 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A metaanalysis of randomised trials
    • Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A metaanalysis of randomised trials. Lancet. 2014;383:955-962.
    • (2014) Lancet , vol.383 , pp. 955-962
    • Ruff, C.T.1    Giugliano, R.P.2    Braunwald, E.3    Hoffman, E.B.4    Deenadayalu, N.5    Ezekowitz, M.D.6
  • 12
    • 84868523625 scopus 로고    scopus 로고
    • 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
    • ESC Committee for Practice Guidelines (CPG)
    • Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al; ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719-2747.
    • (2012) Eur Heart J , vol.33 , pp. 2719-2747
    • Camm, A.J.1    Lip, G.Y.2    De Caterina, R.3    Savelieva, I.4    Atar, D.5    Hohnloser, S.H.6
  • 14
    • 80155179455 scopus 로고    scopus 로고
    • Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
    • Gallagher AM, Setakis E, Plumb JM, Clemens A, van Staa TP. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost. 2011;106:968-977.
    • (2011) Thromb Haemost , vol.106 , pp. 968-977
    • Gallagher, A.M.1    Setakis, E.2    Plumb, J.M.3    Clemens, A.4    Van Staa, T.P.5
  • 15
    • 79958126202 scopus 로고    scopus 로고
    • Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial
    • Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation. 2011;123:2363-2372.
    • (2011) Circulation , vol.123 , pp. 2363-2372
    • Eikelboom, J.W.1    Wallentin, L.2    Connolly, S.J.3    Ezekowitz, M.4    Healey, J.S.5    Oldgren, J.6
  • 16
    • 80054071757 scopus 로고    scopus 로고
    • Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
    • Fox KA, Piccini JP, Wojdyla D, Becker RC, Halperin JL, Nessel CC, et al. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J. 2011;32:2387-2394.
    • (2011) Eur Heart J , vol.32 , pp. 2387-2394
    • Fox, K.A.1    Piccini, J.P.2    Wojdyla, D.3    Becker, R.C.4    Halperin, J.L.5    Nessel, C.C.6
  • 17
    • 84869100588 scopus 로고    scopus 로고
    • Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: Insights from the ARISTOTLE trial
    • Hohnloser SH, Hijazi Z, Thomas L, Alexander JH, Amerena J, Hanna M, et al. Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J. 2012;33:2821-2830.
    • (2012) Eur Heart J , vol.33 , pp. 2821-2830
    • Hohnloser, S.H.1    Hijazi, Z.2    Thomas, L.3    Alexander, J.H.4    Amerena, J.5    Hanna, M.6
  • 18
    • 84864379749 scopus 로고    scopus 로고
    • Rivaroxaban vs. Warfarin in Japanese patients with atrial fibrillation-the J-ROCKET AF study
    • J-ROCKET AF Study Investigators
    • Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, et al; J-ROCKET AF Study Investigators. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation-the J-ROCKET AF study. Circ J. 2012;76:2104-2111.
    • (2012) Circ J , vol.76 , pp. 2104-2111
    • Hori, M.1    Matsumoto, M.2    Tanahashi, N.3    Momomura, S.4    Uchiyama, S.5    Goto, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.